Dr. Steven A Limentani MD Hematologist

Dr. Steven Limentani is a hematologist in Charlotte, North Carolina. He is affiliated with multiple hospitals in the area, including Carolinas Medical Center and Carolinas Medical Center -Pineville. He received his medical degree from Tufts University School of Medicine and has been in practice for 28 years. He is one of 20 doctors at Carolinas Medical Center and one of 10 at Carolinas Medical Center -Pineville who specialize in Hematology.

Are you Dr. Steven Limentani? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

Carolinas Medical Center
High performing in Cancer

Carolinas Medical Center -Pineville

University of North Carolina Hospitals
Ranked #43 in Cancer

Education & Medical Training

Beth Israel Deaconess Medical Center
Residency, Internal Medicine, 1986 - 1989

Tufts Medical Center
Fellowship, Medical Oncology, 1989 - 1992

Tufts University School of Medicine
Class of 1986

Certifications & Licensure

American Board of Internal Medicine
Certified in Hematology

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

MA State Medical License
Active through 2014

NC State Medical License
Active through 2014

Publications & Presentations

Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
Detterbeck, F.C., Socinski, M.A., Gralla, R.J., Edelman, M.J., Jahan, T.M., Loesch, D.M., Limentani, S.A., Govindan, R., Zaman, M.B., Ye, Z., Monberg, M.J., Obasaju, C.K.

Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
Limentani, S.A., Brufsky, A.M., Erban, J.K., Jahanzeb, M., Lewis, D.

Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
Fanucchi, M.P., Fossella, F.V., Belt, R., Natale, R., Fidias, P., Carbone, D.P., Govindan, R., Raez, L.E., Robert, F., Ribeiro, M., Akerley, W., Kelly, K., Limentani, S.A., Crawford, J., Reimers, H., Axelrod, R., Kashala, O., Sheng, S., Schiller, J.H.

See all 33 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • Anthem Blue Preferred Plus POS
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
  • WEA Trust Preferred Provider Plan - Trust Pref
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.